This analysis showed significant CD8+ and CD4+ T-cell infiltration after subasumstat administration in samples from CPI-naïve (cervical cancer) and CPI-exposed (melanoma and NSCLC) patients; no significant changes in regulatory T cells were observed (Supplementary Fig. S8). This evidence concerns the gene CD8A and melanoma.